Close

PILULKA LÉKÁRNY

Period:
 - 
Change in selected period :
Source:
Turnover in CZK

Intraday data


Date & Time
05.12.2025 | 15:49:22
Last
CZK 170.00
Change
-1,73 %
Change Abs.
CZK -3.00
ISIN
CZ0009009874
L
MPQ
Post Trade
IPO price
CZK 424.00
Note

Information and documents related to initial subscriptions and public offerings can be found in the Subscriptions section.

Basic Information

Market MTF
Market Segment Start Market
Type Of Security Shares
Ticker Bloomberg PINK CP Equity
Ticker Reuters PINK.PR
Ticker Xetra® PINK
Shares Included 2 706 678 pcs
Market Capitalization CZK 460.14 mio.

Indicators

YTD Performance 58,14 %

Included in the following indices

Name Last Change
PX-START 1,192.40 0,21 %

Trading

Trading Procedure Continuous trading
Trading Unit Pieces
Trading Hours 08:50 - 16:25
Time Of Opening Auction 8:50
Time Of Closing Auction 16:10
Trade At Close 16:15
Trading Currency CZK
First Day of Trading 26. 10. 2020
  • Calculated by Vienna Stock Exchange (Wiener Börse AG)

Market Depth

Prices 15 minutes delayed

Time Axis

Start End
Bid/Ask -/-
Bid Size/Ask Size -/-
Open CZK 173.00
High CZK 176.00
Low CZK 167.00
Last Close CZK 173.00
Last Volume 60
Total Turnover in Pcs 3 480 pcs
Total Turnover in CZK CZK 594,994.00
Number of Trades 0
Year High CZK 260.00
Year Low CZK 84.00
From
To
Search
Change in selected period
Turnover in selected period |
Company
Pilulka Lékárny a.s.
Address
Českomoravská 2408/1a, 190 00, Praha
Website Company Profile
Pilulka Lékárny is a technology company operating in the Czech Republic and Slovakia. It operates brick-and-mortar pharmacies and an e-shop, which, among other things, also focuses on the sale of medicines, sports nutrition, food supplements or children's supplies.
last update: 06.11.2025 16:10
DISCLAIMER: Financial data are provided to Prague Stock Exchange, a.s. by individual issuers who are responsible for their accuracy. Data are taken from the issuer´s annual reports which are published in the company profile&reports section, and also on the issuer´s website: https://www.pilulka.cz/pro-investory. Prague Stock Exchange, a.s. does not provide any guarantees for the published data, is not responsible for any typing errors or omissions, or for any decisions taken on such data. More information: https://www.pse.cz/en/legal-information.


XLSX export
last update: 05.12.2025 18:10
last update: 05.12.2025 18:10

NOTES:

1. The preliminary financial results and annual report relate to the previous financial year.

2. The calendar lists the date of the general meeting, at which, among other things, the financial statements for the previous financial year are approved.

3. Dates marked with * cannot be saved to your electronic calendar. Other future events can be saved to your electronic calendar (Google or MS Outlook), but only the date will be saved, without a specific time. The dates of future events may change during the year. If a change occurs, the previously saved date will not be automatically adjusted in the electronic calendar. The event must be saved again. Related documents can be downloaded for historical events.


DISCLAIMER:
The dates provided are supplied to the Prague Stock Exchange by individual issuers, who are responsible for their accuracy. The Prague Stock Exchange does not provide any guarantees for the data and is not responsible for any errors or typos, or for any decisions based on this data. For more information, visit https://www.pse.cz/en/legal-information. Dates marked with * are not filled in by the issuer; they are deadlines set by stock exchange rules.

PILULKA LÉKÁRNY: established to consolidate a fragmented business

In the late 90s the Kasa brothers were the pioneers of Czech e-commerce and built one of the largest e-shops back then. Later, they sensed the opportunity in a lucrative but conservative and fragmented healthcare sector, and Pilulka.cz was born.

SUCCESSFULLY LISTED
View full story

Disclaimer: The text on this website does not constitute an offer or invitation to sell or buy investment instruments or a recommendation to trade investment instruments. Investors should consult their legal, financial and other professional advisors before making investment decisions. Investors should also read the contents of the prospectus and other documents containing information about a particular investment instrument and its issuer before making an investment decision in order to fully understand the potential risks associated with a decision to invest in that investment instrument. The prospectus of a security shall always be available in electronic form on the issuer's website before the commencement of the public offer or before the admission of the security to trading on a regulated market.